117 related articles for article (PubMed ID: 14553948)
1. Microsatellite alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Koo SH; Ihm CH; Kwon KC; Lee JS; Park JW; Kim JW
Cancer Genet Cytogenet; 2003 Oct; 146(2):139-44. PubMed ID: 14553948
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Koo SH; Ihm CH; Kwon KC; Park JW; Kim JM; Kong G
Cancer Genet Cytogenet; 2001 Oct; 130(1):22-8. PubMed ID: 11672769
[TBL] [Abstract][Full Text] [Related]
3. Allelotypic characteristics of thorotrast-induced intrahepatic cholangiocarcinoma: comparison to liver cancers not associated with thorotrast.
Liu D; Wada I; Tateno H; Ogino D; Suzuki M; Li L; Lu W; Kojiro M; Fukayama M; Okabe H; Fukumoto M
Radiat Res; 2004 Feb; 161(2):235-43. PubMed ID: 14731065
[TBL] [Abstract][Full Text] [Related]
4. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
Chang YC; Ho CL; Chen HH; Chang TT; Lai WW; Dai YC; Lee WY; Chow NH
Br J Cancer; 2002 Dec; 87(12):1449-53. PubMed ID: 12454776
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization.
Uhm KO; Park YN; Lee JY; Yoon DS; Park SH
Cancer Genet Cytogenet; 2005 Feb; 157(1):37-41. PubMed ID: 15676145
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
Cazals-Hatem D; Rebouissou S; Bioulac-Sage P; Bluteau O; Blanché H; Franco D; Monges G; Belghiti J; Sa Cunha A; Laurent-Puig P; Degott C; Zucman-Rossi J
J Hepatol; 2004 Aug; 41(2):292-8. PubMed ID: 15288479
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive allelotyping of human intrahepatic cholangiocarcinoma.
Momoi H; Okabe H; Kamikawa T; Satoh S; Ikai I; Yamamoto M; Nakagawara A; Shimahara Y; Yamaoka Y; Fukumoto M
Clin Cancer Res; 2001 Sep; 7(9):2648-55. PubMed ID: 11555575
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular and cholangiolar carcinoma-derived cell lines reveal distinct sets of chromosomal imbalances.
Wilkens L; Hammer C; Glombitza S; Müller DE
Pathobiology; 2012; 79(3):115-26. PubMed ID: 22261732
[TBL] [Abstract][Full Text] [Related]
9. Genetic classification of combined hepatocellular-cholangiocarcinoma.
Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
[TBL] [Abstract][Full Text] [Related]
10. Allelotype analysis of intrahepatic cholangiocarcinoma.
Kang YK; Kim YI; Kim WH
Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite alterations in liver fluke related cholangiocarcinoma are associated with poor prognosis.
Limpaiboon T; Krissadarak K; Sripa B; Jearanaikoon P; Bhuhisawasdi V; Chau-in S; Romphruk A; Pairojkul C
Cancer Lett; 2002 Jul; 181(2):215-22. PubMed ID: 12175538
[TBL] [Abstract][Full Text] [Related]
12. Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Wang Y; Hong Y; Li M; Long J; Zhao YP; Zhang JX; Li Q; You H; Tong WM; Jia JD; Huang J
PLoS One; 2013; 8(12):e82426. PubMed ID: 24349281
[TBL] [Abstract][Full Text] [Related]
13. Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma.
You HL; Weng SW; Li SH; Wei YC; Sheu JJ; Chen CM; Huang WT
Exp Mol Pathol; 2012 Jun; 92(3):281-6. PubMed ID: 22366251
[TBL] [Abstract][Full Text] [Related]
14. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
15. Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma.
Murugesan K; Sharaf R; Montesion M; Moore JA; Pao J; Pavlick DC; Frampton GM; Upadhyay VA; Alexander BM; Miller VA; Javle MM; Bekaii Saab TS; Albacker LA; Ross JS; Ali SM
JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34476330
[TBL] [Abstract][Full Text] [Related]
16. [Frequency of loss of heterozygosity on chromosome 17 in intrahepatic cholangiocarcinoma].
Kim HJ; Kang CD; Lee SJ; Cho SJ; Kim JS
Korean J Gastroenterol; 2006 Sep; 48(3):188-94. PubMed ID: 17047434
[TBL] [Abstract][Full Text] [Related]
17. Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study.
Cong WM; Bakker A; Swalsky PA; Raja S; Woods J; Thomas S; Demetris AJ; Finkelstein SD
J Cancer Res Clin Oncol; 2001; 127(3):187-92. PubMed ID: 11260864
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma.
Momoi H; Itoh T; Nozaki Y; Arima Y; Okabe H; Satoh S; Toda Y; Sakai E; Nakagawara K; Flemming P; Yamamoto M; Shimahara Y; Yamaoka Y; Fukumoto M
J Hepatol; 2001 Aug; 35(2):235-44. PubMed ID: 11580146
[TBL] [Abstract][Full Text] [Related]
19. MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients.
Baudhuin LM; Roberts LR; Enders FT; Swanson RL; Mettler TA; Aderca I; Stadheim LM; Highsmith WE
J Cancer Res Clin Oncol; 2006 Mar; 132(3):159-62. PubMed ID: 16292541
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]